IRODALOM
1. Adam G., Bücker A. et al: Interventional MR imaging: percutaneous abdominal and skeletal
biopsies and drainages of the abdomen. Eur. Radiol., 1999, 9, 1471-1478.
2. Aschoff AJ., Görich J. et al.: Pancreas: Does hyosciamine butylbromide increase the
diagnostic value of helical CT? Radiology, 1999, 210, 861-864.
247
3. Bartolozzi C., Lenzioni R. et al.: Abdominal MR: liver and pancreas.
4. (review article). Eur.Radiol., 1999, 9, 1496-1512.
5. Boland G.W., O’Malley M.E.: Pancreatic-phase versus portal vein-phase helical CT of the
pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR, 1999,
172, 605-608.
6. De Jaegere T., Van Hoe L. et al.: Screening applications for MRI in the detection of upper
abdominal disease: comparative study of non-contrast-enhanced single-shot MRI and
contrast-enhanced helical CT. Eur.Radiol., 1999, 9, 853-861.
7. Diehl S.J., Lehmann K.-J. et al.: Wertigkeit von Magnetresonanz-tomographie (MRT),
Magnetresonanz-Cholangiopankreatikographie (MRCP) und endoskopischer retrograder
Cholangiopankreatikographie (ERCP) bei der Diagnose von Pankreastumoren. Fortschr.
Röntgenstr., 1999, 170, 463-469.
8. Efremidis S.C., Vougiouklis N. et al.: Pathways of lymph node involvement in upper
abdominal malignancies: evaluation with high-resolution CT. Eur.Radiol., 1999, 9, 868-874.
9. Gaa J., Wendl K.: Kombinierter Einsatz von MRT, MRCP und kontrastverstärkter 2-Phasen
3D-MRA in der Diagnostik von Pankreatumoren: Erste klinische Ergebnisse. Fortschr.
Röntgenstr., 1999, 170, 528-533.
10. Katsuyoshi I., Mitchell E.K. et al.: Pancreatic changes in primary sclerosing cholangitis:
evaluation with MR imaging. AJR, 1999, 173, 1535-1539.
11. Katz D. S., Hines J. et al.: Using CT to reveal fat-containing abnormalities of the pancreas.
AJR, 1999, 172, 393-396.
12. Lázár I., Charifi A-B.: Insulinoma localisatiója selectiv intraarteriális calciumos
stimulatióval. Magyar Radiológia, 1999, 73, 3, 67-72.
13. Lev-Toaff A.S., Langer J.E. et al.: Safety and efficacy of a new oral contrast agent for
sonography: A phase II trial. AJR., 1999, 173, 431-436.
14. Lorén I., Lasson Á. et al.: New sonographic imaging observations in focal pancreatitis. Eur
Radiol., 1999, 9, 862-867.
15. Maubon A.J., Ferru J. et al.: Effect of field strength on MR images: comparison of the same
subject at 0,5, 1,0, and 1,5 T. RadioGraphics, 1999, 19, 1057-1067.
16. Merkle E.M., Haaga J.R. et al.: MR Imaging-guided radio-frequency thermal ablation in the
pancreas in a porcine model with a modified clinical C-arm system. Radiology, 1999, 213,
461-467.
17. Park CH.M., Cha I.H. et al.: Hyperdense enhancement of pancreatic adenocarcinoma on
spiral CT: two case reports. Clinical Imaging, 1999, 23, 187-189.
18. Soyer Ph., Spelle L. et al.: Cystic fibrosis in adolescents and adults: fatty replacement of the
pancreas – CT evaluation and functional correlation. Radiology, 1999, 210, 611-615.
19. Stattaus J., Mertens H. et al.: Metastasen eines Nierenzell-karzinoms in Pankreas und
Gallenblase – Möglichkeiten und Grenzen der MRT-Diagnostik. Fortschr. Röntgenstr., 1999,
170, 598-600.
20. Tabuchi T., Itah K. et al.: Tumor staging of pancreatic adenocarcinoma using early- and
late-phase helical CT. AJR, 1999, 173, 375-380.
